Alaleh Nouri is CLO & VP +1 at PROCEPT BioRobotics Corp (PRCT). They have made 21 open-market trades across 2 companies since 2014, most recently 2026-09-09.
CIK 0001599418
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRCT | 127,737 | $2.3M |
| ARAY | 195,697 | $28K |
| Total | $2.4M |
Shares reported on the most recent Form 4, priced at the 2026-09-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRCT | SELL | 2026-09-09 | 2026-09-10 | $20.95 | $6K | -9.9% | -4.3% | — |
| PRCT | SELL | 2026-06-08 | 2026-06-10 | $28.48 | $8K | -25.9% | -24.8% | -23.2% |
| PRCT | SELL · 10b5-1 | 2026-03-19 | 2026-03-19 | $25.96 | $278K | -3.7% | -0.9% | -19.5% |
| PRCT | SELL | 2026-03-17 | 2026-03-19 | $28.15 | $17K | -3.7% | -0.9% | -19.5% |
| PRCT | SELL | 2026-03-10 | 2026-03-12 | $25.65 | $83K | -3.9% | -10.1% | +11.4% |
| PRCT | SELL | 2026-03-06 | 2026-03-09 | $23.70 | $163K | -4.4% | -11.2% | +5.5% |
| PRCT | SELL | 2025-03-18 | 2025-03-19 | $57.06 | $18K | +1.3% | -7.1% | +2.6% |
| PRCT | SELL | 2025-03-06 | 2025-03-10 | $61.31 | $446K | -0.5% | -6.0% | +8.1% |
| PRCT | SELL · 10b5-1 | 2024-12-04 | 2024-12-06 | $97.13 | $5.5M | -13.5% | -6.8% | -36.2% |
| PRCT | SELL · 10b5-1 | 2024-06-17 | 2024-06-18 | $62.17 | $1.2M | +0.5% | +8.4% | +33.2% |
| PRCT | SELL | 2024-05-03 | 2024-05-03 | $62.99 | $3.8M | +6.4% | +0.8% | -4.6% |
| PRCT | SELL | 2024-03-18 | 2024-03-20 | $48.83 | $22K | -3.6% | +3.9% | +28.4% |
| PRCT | SELL | 2024-03-06 | 2024-03-07 | $46.67 | $257K | +0.6% | -0.7% | +38.2% |
| PRCT | SELL · 10b5-1 | 2024-02-07 | 2024-02-09 | $49.96 | $2.0M | -0.9% | -2.7% | +26.9% |
| PRCT | SELL · 10b5-1 | 2024-01-09 | 2024-01-11 | $44.97 | $720K | -4.8% | +6.1% | +9.7% |
| PRCT | SELL · 10b5-1 | 2023-12-14 | 2023-12-15 | $42.97 | $1.3M | -0.7% | +9.0% | +10.3% |
| PRCT | SELL · 10b5-1 | 2023-12-06 | 2023-12-08 | $39.96 | $487K | +2.6% | +8.2% | +26.4% |
| PRCT | SELL · 10b5-1 | 2023-07-27 | 2023-07-31 | $40.00 | $316K | -7.6% | -1.8% | -27.4% |
| PRCT | SELL | 2023-03-16 | 2023-03-17 | $31.84 | $10K | -13.0% | +17.3% | +11.4% |
| PRCT | SELL | 2022-12-27 | 2022-12-28 | $40.90 | $251K | -13.7% | -7.7% | -32.3% |
| PRCT | SELL | 2022-12-16 | 2022-12-20 | $42.81 | $2.6M | -3.5% | -5.9% | -21.8% |
| PRCT | SELL | 2022-05-16 | 2022-05-16 | $35.06 | $24K | +12.7% | +5.4% | +24.8% |
| ARAY | SELL | 2018-07-03 | 2018-07-03 | $4.08 | $35K | -6.1% | -6.1% | +10.0% |
| ARAY | SELL | 2018-07-03 | 2018-07-06 | $4.00 | $35K | -4.8% | -7.2% | +2.9% |
| ARAY | SELL | 2018-04-03 | 2018-04-03 | $4.65 | $12K | +7.7% | +1.1% | -10.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.